Wikidata

(Q58024747)

English

Phase I/II study to assess safety, pharmacokinetics, and efficacy of the oral MEK 1/2 inhibitor GSK1120212 (GSK212) dosed in combination with the oral BRAF inhibitor GSK2118436 (GSK436)

article by J. R. Infante et al published 20 June 2011 in Journal of Clinical Oncology

In more languages

Statements

title
Phase I/II study to assess safety, pharmacokinetics, and efficacy of the oral MEK 1/2 inhibitor GSK1120212 (GSK212) dosed in combination with the oral BRAF inhibitor GSK2118436 (GSK436) (English)
0 references
author name string
J. R. Infante
series ordinal
1
0 references
G. S. Falchook
series ordinal
2
0 references
D. P. Lawrence
series ordinal
3
0 references
J. S. Weber
series ordinal
4
0 references
R. F. Kefford
series ordinal
5
0 references
J. C. Bendell
series ordinal
6
0 references
R. Kurzrock
series ordinal
7
0 references
G. Shapiro
series ordinal
8
0 references
R. R. Kudchadkar
series ordinal
9
0 references
G. V. Long
series ordinal
10
0 references
H. A. Burris
series ordinal
11
0 references
K. B. Kim
series ordinal
12
0 references
A. Clements
series ordinal
13
0 references
S. Peng
series ordinal
14
0 references
B. Yi
series ordinal
15
0 references
A. J. Allred
series ordinal
16
0 references
D. Ouellet
series ordinal
17
0 references
K. Patel
series ordinal
18
0 references
P. F. Lebowitz
series ordinal
19
0 references
K. T. Flaherty
series ordinal
20
0 references
publication date
20 June 2011
0 references
volume
29
0 references
issue
18_suppl
0 references
page(s)
CRA8503-CRA8503
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q58024747&oldid=2143609975"